![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, December 07, 2013 10:09:26 AM
Titan would likely be attacking outside the US and into subspecialties not currently well represented. It will be interesting to see what happens for hospitals currently with DaVinci that want a second robot. Titan May be much less of a capital expenditure.
In response to adding an additional arm- I'm certainly not a biomedical engineer but the rate limiting step is the port site size to accommodate 4 port entry sites. Unless you want a bigger umbilical incision which defeats "scarless " incisions.
If this happens, gen surg will certainly be doing more umbilical hernia repairs, then you can start investing in mesh companies
FEATURED North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM